Legionnaires’ disease: overview of the situation concerning notification in Wallonia (Belgium) in 2012, a retrospective descriptive study based on a capture-recapture method
© Jacquinet et al.; licensee BioMed Central. 2014
Received: 25 April 2014
Accepted: 28 September 2014
Published: 12 January 2015
Legionnaires’ disease is a severe form of pneumonia, and although public health medical inspectors must be notified, it is often under-reported. The objectives of this study were to determine the completeness rate of notification of Legionnaires’ disease and to estimate the incidence of this disease in Wallonia, the southern part of Belgium, in 2012.
This retrospective, transversal descriptive study was based on a capture-recapture method using two sources. An estimation of the total number of Legionnaires’ disease cases was calculated using Chapman and Seber’s estimators for small numbers, thereby allowing us to estimate the real incidence of this disease in Wallonia as well as the completeness rate of notification.
The total number of estimated Legionella cases for 2012 was 45 (IC 95%:41–48) and the completeness rate was 65% (IC 95%:61-70%). The estimated incidence of Legionnaires’ disease in Wallonia was 1.27/100,000 inhabitants.
The notification rate of Legionella must be improved in Wallonia. Doctors should be made aware of the importance of diagnosing and reporting Legionnaires’ disease.
KeywordsLegionnaires’ disease Surveillance Belgium
Malgré une mortalité et morbidité non négligeables, la maladie du légionnaire est une maladie à déclaration obligatoire auprès des médecins inspecteurs qui est fréquemment sous rapportée. Les objectifs de cette étude furent le calcul de l’exhaustivité de la déclaration obligatoire de la maladie du légionnaire et l’estimation de son incidence en Wallonie, la partie sud de la Belgique, pour l’année 2012.
Cette étude descriptive transversale rétrospective s’est basée sur une méthode capture-recapture à 2 sources. Une estimation du nombre total de cas de maladie du légionnaire a été réalisée en utilisant les estimateurs de Chapman et Seber pour effectifs faibles. Ensuite, l’incidence réelle de la maladie du légionnaire en Wallonie ainsi que l’exhaustivité de la déclaration ont pu être calculées.
Le nombre total de cas estimés de maladie du légionnaire pour l’année 2012 est de 45 (IC 95% : 41–48) et le taux d’exhaustivité de la déclaration obligatoire est de 65% (IC 95% : 61-70%). L’incidence estimée de maladie du légionnaire en région wallonne est de 1,27/100.000 habitants.
Le taux de notification de la maladie du légionnaire doit être amélioré en Wallonie. Les médecins devraient être mieux sensibilisés à la déclaration et au diagnostic de la maladie du légionnaire.
KeywordsLegionnaires’ disease Surveillance Belgium
Legionnaires’ disease is an obstructive pulmonary disease caused by Legionella (gram-negative bacteria). Legionella pneumophila species accounts for 90% of Legionnaires’ disease cases and included 15 different serogroups, among which we find serogroup 1, which causes 70% to 90% of Legionella cases for which a bacteria has been isolated [1, 2].
Legionella is naturally present in freshwater but also grows in the presence of different favouring factors, such as temperatures between 25° and 42°C, the presence of nutrients and protozoa and the possibility to form a biofilm when scale, corrosion and stagnation are present in the water system . Human infection occurs through the inhalation of micro-drops containing bacteria. These droplets can be generated by showers, hot tubes, cooling towers, indoor fountains, humidifiers, respiratory devices and nebulizers .
Legionnaires’ disease is a serious disease which accounts for 0.5 to 10% of hospitalizations of community-acquired pneumonia . Moreover, it is associated with a serious case fatality rate (10%) . It can occur in sporadic cases or outbreaks, affecting many people .
Legionnaires’ disease mainly affects people with some risk factors: the elderly, males, smokers, the presence of a chronic heart or lung disease, diabetes, immunosuppression, end-stage renal failure, neoplasia and hematological malignancy [1–3].
The purposes of this study were to calculate the completeness of notification of Legionnaires' disease and to measure its incidence in Wallonia in 2012.
Contingency table of capture recapture study with 2 sources
Total register B
Total register A
Then, the completeness rate of the source (E) can be calculated. For example, for source A (Table 1), E = NA/N.
The study targeted patients living in Wallonia whose symptoms started between the 1st January 2012 and 31st December 2012.
The study included confirmed or probable Legionnaires' disease cases according to the case definition of the ECDC .
The first source for this study was notification to the Walloon public health medical inspectors in 2012.
The second source was the “acute hospitals” in Wallonia . Specialized chronic-care facilities and psychiatric hospitals were excluded from the study. Given that it is necessary to conduct a laboratory test to diagnose Legionnaires' disease, microbiologists from the different Walloon hospital laboratories were contacted. An information letter describing the study and its methodology was sent to microbiologists early in January 2013. The microbiologists in the concerned laboratories were then contacted by telephone during January. Forty-two laboratories carrying out analyses for the 57 acute hospitals of Wallonia were contacted.
Capture recapture and data analyses
For both sources, a structured questionnaire was used and specific data was collected: the first letter of the surname, the forename, gender, date of birth, postcode, and laboratory tests that was/were used for the diagnosis and the X-ray results. This data was necessary to detect duplication and to ensure those cases corresponded to the definition of the case. Then, both data sources were compared to identify the common cases and those that were present in each of the sources.
Afterwards, the completeness rate of notification was calculated as well as the incidence of Legionnaires' disease (the average in the population figures on 1st January 2012 and on 1st January 2013 ) in Wallonia.
The total number of cases and the incidence were calculated using Excel software (12.0 version).
This study was approved by the ethical committee of Erasmus Hospital in Brussels.
Contingency table of the capture-recapture study of Legionnaires’ disease cases diagnosed in 2012
Source A: notification
Total register B
Total register A
The completeness rate of notification for Legionnaires' disease cases was 65% (IC 95%: 61%-70%).
The estimated incidence of Legionnaires’ disease in Wallonia is thus 12.7 per million inhabitants.
The estimated incidence of Legionnaires' disease in Wallonia in 2012 (12.7 per million inhabitants) was quite close to the European average of 12.4 per million inhabitants in 2010  and that of the United States of 11.5 per million inhabitants . However, the incidence was very far from the one expected in Europe by the ECDC. Two estimations of the expected incidence of Legionnaires' disease in Europe have been made by the ECDC to-date. The first estimation was 20 per million inhabitants  by choosing Denmark as a reference because it is a small country whose incidence of Legionnaires’ disease has remained constant for several years and which conducts a high number of diagnostic tests for Legionnaires' disease. A second incidence was calculated theoretically in 2009  (starting from a theoretical incidence of pneumonia and by estimating that the proportion of pneumonia due to Legionella is 4%). It estimates the real incidence of Legionnaires' disease at 103 per million inhabitants.
An explanation for the low incidence could be the under-diagnosis of the disease and there are various reasons that are connected to it. A lack of sensitivity in some diagnostic methods and the very frequent use of urine testing which only detects L.pneumophila of serogroup 1 is the first cause of under-diagnosis . Legionnaires' disease is known to cause severe cases of pneumonia: a moderate clinical picture of lung infection doesn’t always lead to the diagnosis of Legionnaires' disease  and pneumonia reported in Wallonia in 2012 was diagnosed exclusively among hospitalized patients.
Another cause of under-diagnosis is the immediate use of empirical antibiotic therapy for pneumonia especially in severe cases. This treatment is, among others, justified for Legionnaires' disease because a rapid response diminishes the risk of mortality . If the antibiotic is effective against legionella, the patient will recover and the medical doctor won't see the necessity in searching for the cause of the pneumonia .
The completeness rate of notification in Wallonia is estimated at 65%. Other European countries conducted capture-recapture studies in order to measure their completeness: in 2002 it was estimated at 78.6% in Italy , in France in 2010 at 88.5%  and in the Netherlands in 2000–2001 at 42.1% . European rates are rather heterogeneous and Wallonia’s one shows there could be a significant number of Legionnaires' disease cases for which no investigation was conducted to determine the source of contamination and for which no control measures were taken. Moreover, under-reporting makes it impossible to evaluate the real impact of the disease on a public health level.
The reasons for under-reporting diseases with mandatory declaration are numerous: a lack of knowledge concerning the list of diseases that must be reported, the reporting method or even the existence of notification are the main causes [17, 18]. Among doctors that are well informed about the notification, the belief that another colleague will report it, a lack of time and the cumbersome procedure are also mentioned. Some doctors also refuse to notify (the investigation in France in 2005 shows that 16% of informed doctors refused to report) . This refusal can probably be explained by a lack of awareness of the importance of notification on public health.
In Wallonia, no study has yet been conducted to analyze the reasons for under-reporting and a great number of the reasons mentioned above should probably be taken into account. However, the reporting procedure is rather simple and can be done in several ways, among others, by an internet interface, and in all cases by straightforward reporting to the public health medical inspector without intermediaries.
Concerning the methodological aspects, the use of Walloon hospitals as a second source makes it possible to capture only hospitalized cases. But, Legionnaires' disease can also present as a moderate case of pneumonia  and thus, occur among non-hospitalized patients, which could be interpreted as a methodological weakness in this study. However, Legionnaires’ disease is unlikely to be diagnosed among non-hospitalized patients because the recommendations in that matter are not geared towards research of etiologic pathogens among non-hospitalized patients . In France, between 1998 and 2008 only 2% of reported Legionella cases were not hospitalized , which still supports the hypothesis that very few cases are diagnosed on an out-patient basis.
Given that, in this study, laboratories were obliged to report all results, including those sent to a private laboratory, all hospitalized cases were thus, in principle, identified. However, microbiologists, who don’t usually report Legionnaires' disease cases, may have omitted to notify some cases during the capture-recapture investigation. Moreover, as the data retrieval in laboratories isn’t always computerized, some cases may not have been reported.
Brussels and Flemish hospitals were not included in the second source as some patients residing in Wallonia and hospitalized in these regions may not have been identified. However, for 2012, no Walloon case was declared by Flanders and only one Walloon case was declared by a Brussels hospital.
The response rate of 100% from hospitals leads us to conclude that a vast majority of Legionnaires' disease cases among hospitalized patients were identified.
Most of the assumptions of the capture-recapture study have been respected: the case definition was the same for both sources, the cases appeared during the same period and in the same geographical zone and all the common cases were fully identified [21, 22]. However, in human conditions, limitations are described for the following assumptions: close population, homogeneous population and independence of the sources [23, 24]. In this study, a dependence between sources is possible because the microbiologists used to produce the second list were subject to mandatory declaration. It would then be a positive dependence which would lead to an underestimation of the number of Legionnaires' disease cases and thus an overestimation of the completeness [21, 23].
It would have been preferable to conduct that capture-recapture study with three sources to allow us to check the independence of the sources [21, 22]. However, the use of sentinel laboratories or of National Reference Centers as a third source was not possible because it would have lead to a dependence with the first two sources. The Hospital Discharge Record database could, however, have been a third source. They have already been used for that type of study by different countries, among which the Netherlands  and Italy , by researching the cause of certain types of pneumonia according to the ICD-9 CM. The problem we would then be confronted with would be the difference in the case definition.
Given the probable under-diagnosis of this disease in Wallonia and the fact that the completeness rate of notification only reaches 65%, it remains very important to raise awareness amongst doctors of the diagnosis of Legionnaires' disease and to continue to inform them on the necessity and the importance to notify the public health authorities and the usefulness of doing so.
This category of hospitals refers to general hospitals (including university hospitals) with the exception of specialized and geriatric clinical establishments.
European Centre for Diseases Prevention and Control
- ICD-9 CM:
International Statistical Classification of Diseases Ninth Revision Clinical Modification.
I wish to thank, first and foremost, all the microbiologists for their active participation in this study. I also thank Mathias Leroy from Scientific Institute of Public Health of Belgium for drawing the map of Belgium and Anne Douglas for the English corrections.
- Edelstein PH, Cianciotto NP: Legionella. In Principles and practice of infectious diseases, volume 2, 7th edition. Edited by: Mandell GL, Douglas RG, Dolin R. Philadelphia: Churchill Livingstone Elsevier; 2009:2969–2980.Google Scholar
- Fields BS, Benson RF, Besser RE: Legionella and legionnaires’ disease: 25 years of investigation.Clini Microbiol Rev 2002,15(3):506–526. 10.1128/CMR.15.3.506-526.2002View ArticleGoogle Scholar
- World Health Organization: Legionella and the prevention of Legionaires’ disease. Edited by: Bartram B, Chartier Y, Lee JV, Pond K, Surman-Lee S. Geneva; 2007.Google Scholar
- European Centre for Disease Prevention and Control: Legionnaires’disease in Europe 2010. Stockholm; 2012.Google Scholar
- Chapman DG: Some properties of the hypergeometric distribution with applications to zoological censures.Univ California Public Stat 1951, 1:131–160.Google Scholar
- Seber GAF: The effects of trap response on tag recapture estimates.Biometrics 1970, 26:13–22. 10.2307/2529040View ArticleGoogle Scholar
- European Commission: Decision 2012/506/EU EC laying down case definitions for reporting communicable diseases to the Community network.Off J Eur Union 2012. [http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:262:0001:0057:EN:PDF]Google Scholar
- Belgian Federal Government: Hôpitaux. [http://www.belgium.be/fr/sante/soins_de_sante/services_medicaux/hopitaux/]
- Belgian Federal Government, DirectionGgénérale Statistique et Information Economique (DGSIE): Population résidente totale pour la Belgique et les régions, 2003–2013. [http://statbel.fgov.be/fr/statistiques/chiffres/population/structure/residence/]
- Centers for Disease Control and Prevention: Legionaires’ disease – United States, 2000–2009.MMWR Morb Mortal Wkly Rep 2011,60(32):1083–1086.Google Scholar
- Joseph CA, European Working Group For Legionella Infection: Legionnaire’s disease in Europe 2000–2002.Epidemiol Infect 2004,132(3):417–424. 10.1017/S0950268804002018View ArticlePubMedPubMed CentralGoogle Scholar
- European Centre for Disease Prevention and Control: Legionnaires’disease in Europe 2009. Stockholm; 2011.Google Scholar
- European Centre for Disease Prevention and Control: European Legionnaires’Disease Surveillance Network (ELDSNet): Operating procedures. Stockholm; 2012.Google Scholar
- Rota MC, Cawthorne A, Bella A, Caporali MG, Filia A, d’Ancona F: Capture-recapture estimation of underreporting of legionellosis cases to the National Legionellosis Register: Italie 2002.Epidemiol Infect 2007,135(6):1030–1036. 10.1017/S0950268806007667View ArticlePubMedGoogle Scholar
- Institut de Veille Sanitaire: Evaluation quantitative du système de surveillance des légionelloses en France en 2010. Saint-Maurice; 2012.http://opac.invs.sante.fr/doc_num.php?explnum_id=8117Google Scholar
- Van Hest NA, Hoebe CJ, den Boer JW, Vermunt JK, Ijzerman EP, Boersma WG, Richardus JH: Incidence and completeness of notification of Legionnaires’ disease in the Netherlands: covariate capture-recapture analysis acknowledging regional differences.Epidemiol Infect 2008, 136:540–550.PubMedGoogle Scholar
- Herida M, Pillonel J, le Strat Y, Desenclos JC, Saura C: Évaluation du dispositif des maladies à déclaration obligatoire en France: connaissances, attitudes et pratiques des médecins et des biologistes, 2005.Bull Epidémiol Hebd 2008, 51–52:503–507.Google Scholar
- Friedman SM, Sommersall LA, Gardam M, Arenovich T: Suboptimal reporting of notifiable diseases in Canadian emergency departments: a survey of emergency physician knowledge, practices, and perceived barriers.Can Commun Dis Rep 2006,32(17):187–198. [http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06vol32/dr3217a-eng.php]PubMedGoogle Scholar
- Mandell LA, Wunderink RG, Anzueto A, Lionel A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community acquired pneumonia in adults.Clin Infect Dis 2007,44(Suppl 2):27–72.View ArticleGoogle Scholar
- Campese C, Bitar D, Jarraud S, Maine C, Forey F, Etienne J, Desenclos JC, Saura C, Che D: Progress in the surveillance and control of legionella infection in France, 1998–2008.Int J Infect Dis 2011,15(1):30–37. 10.1016/j.ijid.2010.09.007View ArticleGoogle Scholar
- Van Hest R: Capture-recapture methods in surveillance of tuberculosis and other infectious diseases. PhD thesis. Erasmus MC, University Medical Center Rotterdam; 2007.Google Scholar
- International Working Group for Disease Monitoring and Forecasting: Capture-recapture and multiple-record systems estimation I: history and theoretical development.Am J Epidemiol 1995,142(10):1047–1058.Google Scholar
- Brenner H: Use and limitations of the capture-recapture method in disease monitoring with two dependent sources.Epidemiology 1995,6(1):42–48. 10.1097/00001648-199501000-00009View ArticlePubMedGoogle Scholar
- Hook EB, Regal RR: Capture-recapture methods in epidemiology: methods and limitations.Epidemiol Rev 1995,17(2):243–264.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.